Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis (Q33798492)

29 July 2017

Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

V Balasubramanian

1

1 reference

29 July 2017

Suresh Solapure

2

1 reference

29 July 2017

Radha Shandil

3

1 reference

29 July 2017

Sheshagiri Gaonkar

4

1 reference

29 July 2017

K N Mahesh

5

1 reference

29 July 2017

Jitender Reddy

6

1 reference

29 July 2017

Abhijeet Deshpande

7

1 reference

29 July 2017

Sowmya Bharath

8

1 reference

29 July 2017

Naveen Kumar

9

1 reference

29 July 2017

Lindsay Wright

10

1 reference

29 July 2017

David Melnick

11

1 reference

29 July 2017

Scott L Butler

12

1 reference

29 July 2017

language of work or name

English

0 references

publication date

12 May 2014

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 July 2017

58

1 reference

29 July 2017

7

1 reference

29 July 2017

4185-4190

1 reference

Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Linezolid for treatment of chronic extensively drug-resistant tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

PA-824 exhibits time-dependent activity in a murine model of tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

Linezolid-induced inhibition of mitochondrial protein synthesis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

New classes of antibacterial oxazolidinones with C-5, methylene O-Linked heterocyclic side chains

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068583

30 October 2018

Identifiers

DOI

10.1128/AAC.00137-14

1 reference

release_h2zxdtt445enzot76xrntes2nq

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h2zxdtt445enzot76xrntes2nq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

4068583

1 reference

29 July 2017

1 reference